13
Views
4
CrossRef citations to date
0
Altmetric
Review Articles

Chromosome microarray analysis in a clinical environment: new perspective and new challenge

, , , , , , , & show all
Pages 100-108 | Accepted 13 Dec 2010, Published online: 23 May 2016

References

  • Lejeune J, Gautier M, Turpin R. Study of somatic chromosomes from 9 mongoloid children (in French). C R Hebd Seances Acad Sci 1959; 248: 1721–22.
  • Baldwin EL, Lee JY, Blake DM et al. Enhanced detection of clinically relevant genomic imbalances using a targeted plus whole genome oligonucleotide microarray. Genet Med 2008; 10 (6): 415–29.
  • Lejeune J, Lafourcade J, Berger R et al. Three cases of partial deletion of the short arm of chromosome 5 (in French). C R Hebd Seances Acad Sci 1963; 257: 3098–102.
  • Beijani BA, Shaffer LG. Clinical utility of contemporary molecular cytogenetics. Annu Rev Genomics Hum Genet 2008; 9: 71–86.
  • Speicher MR, Carter NP. The new cytogenetics: blurring the boundaries with molecular biology. Nat Rev Genet 2005; 6 (10): 782–92.
  • Shinawi M, Cheung SW. The array CGH and its clinical applications. Drug Discov Today 2008; 13 (17–18): 760–70.
  • Martin CL, Nawaz Z, Baldwin EL et al. The evolution of molecular ruler analysis for characterizing telomere imbalances: from fluorescence in situ hybridization to array comparative genomic hybridization. Genet Med 2007; 9 (9): 566–73.
  • Shaffer LG, Theisen A, Bejjani BA et al. The discovery of microdeletion syndromes in the post-genomic era: review of the methodology and characterization of a new 1q41q42 microdeletion syndrome. Genet Med 2007; 9 (9): 607–16.
  • Miller DT, Adam MP, Aradhya S et al. Consensus statement: chromosomal microarray is a first tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86: 749–64.
  • Conrad DF, Pinto D, Redon R et al. Origins and functional impact of copy number variation in the human genome. Nature 2010; 464: 704–12.
  • Ji Y, Eichler EE, Schwartz S, Nicholls RD. Structure of chromosomal duplicons and their role in mediating human genomic disorders. Genome Res 2000; 10: 597–610.
  • Thomas NS, Durkie M, Potts G et al. Parental and chromosomal origins of microdeletion and duplication syndromes involving 7q11.23, 15q11-13 and 22q11. Eur J Hum Genet 2006; 14: 831–7.
  • Potocki L, Chen KS, Park SS et al. Molecular mechanism for duplication 17p11.2 – the homologous recombination reciprocal of the Smith-Magenis microdeletion. Nat Genet 2000; 24: 84–7.
  • Baumer A, Dutly F, Balmer D et al. High level of unequal meiotic crossovers at the origin of the 22q11.2 and 7q11.23 deletions. Hum Mol Genet 1998; 7: 887–94.
  • Peng HH, Ven den Veyver IB. Clinical application of microarray based comparative genomic hybridization in prenatal diagnosis. Expert Rev Obstet Gynecol 2009; 4 (1): 81–92.
  • Turner DJ, Miretti M, Rajan D et al. The rates of de novo meiotic deletions and duplications causing several genomic disorders in the male germline. Nat Genet 40 (1): 90–5.
  • Torniero C, Bernardina BD, Novara F et al. Dysmorphic features, simplified gyral pattern and 7q11.23 duplication reciprocal to the Williams-Beuren deletion. Eur J Hum Genet 2008; 16: 880–7.
  • Sebat J, Lakshmi B, Troge J et al. Large-scale copy number polymorphism in the human genome. Science 2004; 305 (5683): 525–8.
  • Iafrate J, Feuk L, Rivera MN et al. Detection of large-scale variation in the human genome. Nat Genet 2004; 36: 949–51.
  • Lee C, Iafrate AJ, Brothman AR. Copy number variations and clinical cytogenetic diagnosis of constitutional disorders. Nat Genet 2007; 39 (7 Suppl): S48–54.
  • Conrad DF, Pinto D, Redon R et al. Origins and functional impact of copy number variation in the human genome. Nature 2010; 464: 704–12.
  • Komura D, Shen F, Ishikawa S et al. Genome-wide detection of human copy number variations using high-density DNA oligonucleotide arrays. Genome Res 2006; 16 (12): 1575–84.
  • Macconaill LE, Aldred MA, Lu X, Laframboise T. Toward accurate high-throughput SNP genotyping in the presence of inherited copy number variation. BMC Genomics 2007; 8: 211.
  • Conrad DF, Hurles ME. The population genetics of structural variation. Nat Genet 2007; 39 (7 Suppl): S30–36.
  • Carter NP. Methods and strategies for analyzing copy number variation using DNA microarrays. Nat Genet 2007; 39 (7 Suppl): S16–21.
  • Madsen BE, Villesen P, Wiuf C. A periodic pattern of SNPs in the human genome. Genome Res 2007; 17 (10): 1414–9.
  • Li M, Li C, Guan W. Evaluation of coverage variation of SNP chips for genome wide association studies. Eur J Hum Genet 2008; 16 (5): 635–43.
  • Beaudet AL, Belmont JW. Array-based DNA diagnostics: let the revolution begin. Annu Rev Med 2008; 59: 113–29.
  • Van der Vegt B, de Bock GH, Hollema H, Wesseling J. Microarray methods to identify factors determining breast cancer progression: potentials, limitations, and challenges. Crit Rev Oncol Hematol 2009; 70 (1): 1–11.
  • Gondek LP, Dunbar AJ, Szpurka H, McDevitt MA, Maciejewski JP. SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD. PLoS One 2007; 2 (11): e1225.
  • Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30 (12): e57.
  • Somerville MU, Mervis CB, Young EJ et al. Severe expressivelanguage delay related to duplication of the Williams-Beuren locus. N Engl J Med 2005; 353: 1694–701.
  • Berg JS, Brunetti-Pierri N, Peter SU et al Speech delay and autism spectrum behaviours are frequently associated with duplication of the 7q11.23 Williams-Beuren syndrome region. Genet Med 2007; 9: 427–41.
  • Depienne C, Heron D, Batancur C et al. A. autism, language delay and mental retardation in a patient with 7q11 duplication. J Med Genet 2007; 44: 452–8.
  • Van der Aa N, Rooms L, Vandeweyer G et al. Fourteen new cases contribute to the characterization of the 7q11.23 microduplication syndrome. Eur J Med Genet 2009; 52: 94–100.
  • Stromme P, Bjornsta PG, Ramstad K. Prevalence estimation of Williams syndrome. J Child Neurol 2002; 17: 269–71.
  • Francke U. Williams-Beuren syndrome: genes and mechanisms. Hum Mol Genet 1999; 8: 1947–54.
  • Peoples R, Franke Y, Wang YK et al. A physical map, including a BAC/PAC clone contig. of the Williams-Beuren syndromedeletion region at 7q11.23. Am J Hum Genet 2000; 66: 47–68.
  • De Silva U, Elnitski L, Idol JR et al. Generation and comparative analysis of approximately 3.3Mb of mouse genomic sequence orthologous to the region of human chromosome 7q11.23 implicated in Williams syndrome. Genome Res 2002; 12: 3–15.
  • Merla G, Ucla C, Guipponi M, Reymond A. Identification of additional transcripts in the Williams-Beuren syndrome critical region. Hum Genet 2002; 110: 429–38.
  • Hoogenraad CC, Eussen BHJ, Langeveld A et al. The murine CYLN2 gene: genomic organization, chromosome localization, and comparison to the human gene that is located within the 7q11.23 Williams syndrome critical region. Genomics 1998; 53: 348-358.
  • Meng Y, Zhang Y, Tregoubov V et al. Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice. Neuron 2002; 35: 121–33.
  • Tassabehji M. Williams-Beuren syndrome: a challenge for genotype-phenotype correlations. Hum Mol Genet 2003; 15: 229–37.
  • Tassabehji M, Hammon P, Karmiloff-Smith A et al. GTF21RD1 in craniofacial development of humans and mice. Science 2005; 310: 1184–7.
  • Cusco I, Corominas R, Bayes M et al. Copy number variation at the 7q1.23 segmental duplications is a susceptibility factor for the Williams-Beuren syndrome deletion. Genome Res 2008; 18 (5): 683–94.
  • Donnai D, Karmiloff-Smith A. Williams syndrome: from genotype through to the cognitive phenotype. Am J Med Genet 2000; 97: 164–71.
  • Ballif BC, Hornor SA, Jenkin E et al. Discovery of a previously unrecognized microdeletion syndrome 16p11.2–p12.2. Nat Genet 2007; 39: 1071–3.
  • Ullman R, Turner G, Kirchhoff M et al. Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation. Hum Mutat 2007; 28: 674–82.
  • Hannes FD, Sharp AJ, Mefford HC et al. Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. J Med Genet 2009; 46 (4): 223–32.
  • Kumar RA, KaraMohamed, Sudi J et al. Recurrent 16p11.2 microdeletion in autism. Hum Mol Genet 2008; 17: 628–38.
  • Marshall CR, Noor A, Vincent JB et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008; 82: 477–88.
  • Weiss LA, Yipin Shen D, Korn JM et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008; 358: 667–75.
  • Girirajan S, Rosenfeld JA, Cooper GM et al. A recurrent 16p12.1 microdeletion support a two-hit model for severe developmental delay. Nat Genet 2010; 42 (3): 203–10.
  • Fombonne E. Epidermiological trends in rates of autism. Mol Psychiatry 2002; 7 (Suppl 2): S4–6.
  • Woodberry KA, Giuliano AJ, Seidman LJ. Premorbid IQ in schizophrenia: a meta-analytic review. Am J Psychiatry 2008; 165: 579–87.
  • Sharp AJ, Mefford HC, Li K et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet 2008; 40: 322–8.
  • Font-Llitjos M, Jimenez-Vial M, Bisceglia L et al. New insights into cystinuria: 40 new mutations, genotype-phenotype correlation, and digenic inheritance causing partial phenotype. J Med Genet 2005; 42: 58–68.
  • Chabrol B, Martens K, Meulemans S et al. Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia-cystinuria syndrome. J Med Genet 2008; 45: 314–8
  • Cabeza-Arvelaiz Y, Thompson TC, Sepulveda JL, Chinault AC. LAPSER1: a novel candidate tumor suppressor gene from 10q24.3. Oncogene 2001; 20: 6707–17.
  • Taylor MD, Liu L, Raffel C et al. Mutations in SUFU predispose to medulloblastoma. Nat Genet 2002; 31: 306–10.
  • Ellison D. Classifying the medulloblastoma: insights from morphology and molecular genetics. Neuropathol Appl Neurobiol 2002; 28: 257–82.
  • Ng D, Stavrou T, Liu L et al. Retrospective family study of childhood medulloblastoma. Am J Med Genet A 2005; 134: 399–403.
  • Lobo S, Cervenka J, London A, Pierpont ME. Interstitial deletion of 10q: clinical features and literature review. Am J Med Genet 1992; 43: 701–3.
  • Brugieres L, Pierron G, Chompre A et al. Incomplete penetrance of the predisposition to medulloblastoma associated with germline SUFU mutations. J Med Genet 2010; 47: 142–4.
  • Bejjani BA, Shaffer LG. Application of array-based comparative genomic hybridization to clinical diagnostics. J Mol Diagn 2006; 8 (5): 528–33.
  • Wordsworth S, Buchanan J, Regan R. Diagnosing idiopathic learning disability: a cost-effectiveness analysis of microarray technology in the National Health Service of the United Kingdom. Genomic Med 2007; 1 (1–2):35–45.
  • Valente EM, Ferraris A, Dallapiccola B. Genetic testing for paediatric neurological disorders. Lancet Neurol 2008; 7 (12): 1113–26.
  • Manning M, Hudgins L. Use of array-based technology in the practice of medical genetics. Genet Med 2007; 9 (9): 650–3.
  • Pergament E. Controversies and challenges of array comparative genomic hybridisation in prenatal genetic diagnosis. Genet Med 2007; 9 (9): 596–9.
  • Bijlsma EK, Gijsbers AC, Schuurs-Hoeijmakers JH et al. Extending the phenotype of recurrent rearrangements of 16p11.2: deletions in mentally retarded patients without autism and in normal individuals. Eur J Med Genet 2009; 52: 77–87.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.